4CPS-066 Changing from cobicistat to a ritonavir boosted regimen in HIV positive patients

Autor: MT Bermejo Vicedo, Má Rodríguez Sagrado, L Quesada-Muñoz, M Rodríguez Marín, M. Vélez-Díaz-Pallarés, N Vicente Oliveros, S Sanz Merino, B Montero Llorente, T Gramage Caro

Publikováno v: Section 4: Clinical Pharmacy Services.

Background and importance Recently, change from cobicistat to ritonavir is being promoted at a tertiary hospital for economic reasons. Therefore, there is a growing need to study what this switch may involve. Aim and objectives Our objective was to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::041fd0b37106343365c184f4323bed28
https://doi.org/10.1136/ejhpharm-2020-eahpconf.167

6ER-009 Patient satisfaction and knowledge after switching from eviplera to odefsey

Autor: M. Vélez-Díaz-Pallarés, N Vicente Oliveros, MJ Vivancos Gallego, A Moreno Zamora, T Gramage Caro, Má Rodríguez Sagrado, M Salgado Del Valle, T. Bermejo Vicedo, B Montero Llorente, Z Santander Sánchez

Publikováno v: Section 6: Education and Research.

Background Tenofovir alafenamide (TAF) is associated with less renal and bone toxicity compared with tenofovir disoproxil (TDF) but with elevation of cholesterol levels. In our hospital, patients were automatically changed from a regimen with Evipler

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afd8e66e50bce0b15dd22ab1cff72cd4
https://doi.org/10.1136/ejhpharm-2019-eahpconf.606

Cost-efficacy analysis of darunavir/r monotherapy in clinical practice

Autor: Má Rodríguez Sagrado, José Sanz, Sonia Moreno, Fernando Dronda, José L. Casado, A. Moreno, Alfonso Muriel, Estrada, Cristina Gómez-Ayerbe, María Martinez-Colubi, M Del Palacio, C Gomez, M Sepulveda, M Pérez Elías

Publikováno v: Journal of the International AIDS Society. 15

Purpose of the study: To evaluate the economic impact of a swiching strategy to DRV/r mx in clinical practice using Spanish prices. Methods: Multicenter retrospective study of four tertiary hospitals in Spain. The analysis includes 147 patients switc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::892d9754c5fad42de59a097544726a8d
https://doi.org/10.7448/ias.15.6.18373

The role of SEAD project intervention in viral suppression of HIV/AIDS patients with follow-up and adherence barriers

Autor: M Pumares Álvarez, L Elías Casado, Fernando Dronda, Alfonso Muriel, D López Pérez, P Marti-Belda, M Pérez Elías, S Moreno Guillén, Cristina Gómez-Ayerbe, Má Rodríguez Sagrado, A Moreno Zamora, María Martinez-Colubi

Publikováno v: Journal of the International AIDS Society

Purpose of study Irregular FUP/ADH were associated with virologic failure [1] leading to an increase in mortality [2]. SEAD was a multidimensional intervention project, designed from the patient's perspective, to specifically attend patients with poo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::528a549d6f8617c06d625d823694c1c1
http://europepmc.org/articles/PMC3512524

Prevalence of HCV infection in a health area of Madrid (Spain): The first step towards microelimination.

Autor: Martínez-Sanz J; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España. Electronic address: javier.martinez.sanz@salud.madrid.org., Muriel A; Unidad de Bioestadística, Hospital Universitario Ramón y Cajal, Madrid, España; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, España., Vivancos-Gallego MJ; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España., Galán JC; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, España; Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España., Romero B; Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España., Rodríguez-Sagrado MÁ; Servicio de Farmacia, Hospital Universitario Ramón y Cajal, Madrid, España., Uranga A; Centro de Salud García Noblejas, Madrid, España., Pérez-Elías P; Centro de Salud García Noblejas, Madrid, España., Barea R; Centro de Salud Canal de Panamá, Madrid, España., Chamorro-Escobar C; Centro de Salud Aquitania, Madrid, España., Herrero-Delgado M; Centro de Salud Mar Báltico, Madrid, España., Pérez-Elías MJ; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España.

Publikováno v: Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2020 Aug - Sep; Vol. 38 (7), pp. 317-322. Date of Electronic Publication: 2019 Dec 07.